Stay updated on Pembrolizumab with CAPOX in Advanced BTC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with CAPOX in Advanced BTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with CAPOX in Advanced BTC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-13T22:05:29.000Z thumbnail image
  5. Check
    4 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the study's progression or results related to the combination of pembrolizumab, capecitabine, and oxaliplatin in treating advanced biliary tract carcinoma.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:18.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying that patients must have histopathological confirmation of biliary tract carcinoma (BTC) and meet other health-related conditions. Previously, the page indicated that no information was provided about participation criteria.
    Difference
    37%
    Check dated 2024-05-22T20:59:13.000Z thumbnail image
  8. Check
    47 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:51:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with CAPOX in Advanced BTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CAPOX in Advanced BTC Clinical Trial page.